Jul 1 |
Eli Lilly inks another radiopharma deal, gaining option to buy startup
|
Jul 1 |
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
|
Jul 1 |
5 Top-Performing S&P 500 Stocks of 1H Set to Shine Further
|
Jul 1 |
Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
|
Jul 1 |
Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
|
Jul 1 |
Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
|
Jul 1 |
Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
|
Jul 1 |
Atossa Therapeutics updates protocol for breast cancer treatment trial
|
Jul 1 |
10 clinical trials to watch in the second half of 2024
|
Jul 1 |
Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
|